Immunohistohemical expression of the chemokine fractalkine and its receptor in the human brain cortex after severe traumatic brain injury and brain hemorrhage

Journal of Neurosurgical Sciences

Volumn 57, Issue 1, 2013, Pages 55-62

  Gaetani, P ^a   Pisano, P ^a   Solinas, G ^a   Colombo, P ^b   Destro, A ^b   Levi, D ^a   Aimar, E ^a   Rodriguez Y Baena, R ^a   Allavena, P ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Brain; Brain injury; Chemokines

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FORMALDEHYDE; FRACTALKINE; PARAFFIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CORRELATIONAL STUDY; DECOMPRESSIVE CRANIECTOMY; FEMALE; GLASGOW OUTCOME SCALE; GLIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; PROTEIN EXPRESSION; PROTEIN MOTIF; SCORING SYSTEM; TRAUMATIC BRAIN INJURY; UPREGULATION;

ADULT; AGED; BRAIN INJURIES; CHEMOKINE CX3CL1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; NEUROGLIA; RECEPTORS, CHEMOKINE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84879014912     PISSN: 03905616     EISSN: 18271855     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Boehme SA, Lio FM, Maciejewski-Lenoir D, Bacon KB, Conlon PJ. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 2000;165:397-403. (Pubitemid 30429532)
2. Fujimura M, Morita-Fujimura Y, Kawase M, Copin JC, Calaoui B, Epstein CJ, Chan PH Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome c and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J Neurosci 1999;19:3414-22. (Pubitemid 29203121)
3. Royo NC, Schouten JW, Fulp CT, Shimizu S, Marklund N, Graham DI et al. From cell death to neuronal regeneration: building a new brain after traumatic brain injury. J Neuropathol Exp Neurol 2003;62:801-11. (Pubitemid 37082774)
4. Stahel PF, Morganti-Kossmann MC, Perez D, Redaelli C, Gloor B, Trentz O et al. Intratechal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury. J Neurotrauma 2001;18:773-81. (Pubitemid 32769773)
5. Adler MW, Rogers TJ. Are chemokines the third major system in the brain? J Lukocyte Biol 2005;78:1204-9. (Pubitemid 41779225)
6. Graham DI, Ford I, Adams JH, Doyle D, Teasdale GM, Lawrence AE, McLellan DR. Ischemic brain damage is still common in fatal nonmissile head injury. J Neurol Neurosurg Psychiatry 1989;52:346-50. (Pubitemid 19075080)
7. Morganti-Kossmann MC, Rancan M, Otto VI, Stahel PF, Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001;16:165-77. (Pubitemid 33598193)
8. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997;385:640-4.
9. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 1997;387:611-7. (Pubitemid 27248766)
10. Tsou CL, Haskell CA, Charo IF. Tumor necrosis factor-alpha-converting enzyme mediates the cleavage of fractalkine. J Biol Chem 2001;276:44622-6.
11. Beck GC, Yard BA, Breedijk AJ, Van Ackern K, Van Der Woude FJ. Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol 1999;118:298-303. (Pubitemid 29519263)
12. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M. Identification and molecular characterization of fractalkine receptor CX3CR-1, which mediates both leukocyte migration and adhesion. Cell 1997;91:521-30. (Pubitemid 27508241)
13. Meucci O, Fatatis A, Simen AA, Miller RJ. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Med USA 2000;97:8075-80. (Pubitemid 30460775)
14. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Med USA 1998;95:10896-901. (Pubitemid 28413165)
15. Maciejevski-Lenoir D, Chen S, Feng L, Maki R, Bacon KB. Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1 expressing microglia. J Immunol 1999;163:1628-35.
16. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 2002;7:314-27.
17. Kastenbauer S, Koedel U, Wick M, Kleseier BC, Hartug HP, Pfister HW. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J Neuroimmunol 2003;137:210-7. (Pubitemid 36355942)
18. Nishiyori A, Minami M, Ohtani Y, Takami S, Yamamoto J, Kawaguchi N et al. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 1998;429:167-72. (Pubitemid 28288203)
19. Schwaeble WJ, Stover CM, Schall TJ, Dairaghi DJ, Trinder PK, Linington C et al. Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett 1998;439:203-7. (Pubitemid 28546645)
20. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM. Control of microglial neurotoxicity by the fractalkine receptor. Nature Neurosci 2006;9:917-24. (Pubitemid 43980506)
21. Rancan M, Bye N, Otto VI, Trentz O, Kossmann T, Frentzel S et al. The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury. J Cerebral Blood Flow Metab 2004;24:1110-8. (Pubitemid 39332150)
22. Zhang X, Graham SH, Kochanek PM, Marion DW, Nathanel PD, Watkins SC et al. Caspase-8 expression and proteolysis in human brain after severe head injury. FASEB J 2003;17;1367-9.
23. Limatola C, Lauro C, Catalano M, Ciotti MT, Bertollini C, Di Angelantonio S. Chemokine CX3CL1 protects rat hyppocampal neurons against glutamate-mediated excitoxicity. J Neuroimmunol 2005;166:19-28. (Pubitemid 41074653)
24. Hainsworth AH, Bermpohl D, Webb TE, Darwish R, Fiskum G, Qiu S et al. Expression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortex. J Cereb Blood Flow Metab 2005;25:1030-40. (Pubitemid 41061718)
25. Qiu J, Whalen MJ, Lowenstein P, Fiskum J, Fahy B, Darkish R et al. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J Neurosci 2002;22:3504-11. (Pubitemid 37465756)
26. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M. Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat. Eur J Neurosci 2002;15:1663-8. (Pubitemid 35471922)
27. Kossmann T, Stahel PF, Lenzlinger PM, Redl H, Dubs RW, Trentz O et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab 1997;17:280-9. (Pubitemid 27161371)
28. Pleines UE, Stover JF, Kossmann T, Trentz O, Morganti-Kossmann MC. Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J Neurotrauma 1998;15:399-409. (Pubitemid 28262274)
29. Bérangère Re DB, Przedborski S. Fractalkine: moving from chemotaxis to neuroprotection. Nature Neurosci 2006;9:859-61. (Pubitemid 43982534)